Related Experiment Videos

PML is induced by oncogenic ras and promotes premature senescence

G Ferbeyre1, E de Stanchina, E Querido

  • 1Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724, USA.

Genes & Development
|August 19, 2000
PubMed

Insights

Oncogenic Ras triggers a senescence-like arrest in human cells. Promyelocytic leukemia (PML) protein accumulates during this arrest, promoting senescence by interacting with Rb and p53 tumor suppressors.

Area of Science:

  • Cellular senescence
  • Tumor suppressor pathways
  • Oncogene-induced cell cycle arrest

Background:

  • Oncogenic Ras proteins are key drivers of cellular transformation.
  • Ras-induced senescence involves the Rb and p53 tumor suppressor pathways.
  • Promyelocytic leukemia (PML) protein is implicated in tumor suppression and nuclear organization.

Purpose of the Study:

  • To characterize gene expression changes during Ras-induced senescence.
  • To investigate the role of PML protein in Ras-induced cell cycle arrest.
  • To elucidate the interaction between PML, Rb, and p53 in senescence.

Main Methods:

  • Comparative gene expression analysis of Ras-arrested and quiescent IMR90 fibroblasts.
  • Assessment of PML protein levels and promyelocytic oncogenic domain (POD) formation.
  • Forced expression of PML and analysis of its effects on senescence markers.
  • Co-localization studies of PML, Rb, and p53.

Main Results:

  • PML protein levels and PODs increase during Ras-induced arrest and replicative senescence.
  • Forced PML expression induces premature senescence.
  • PML enhances Rb and p53 pathway activation, including p16 and p53 targets.
  • PML, Rb, and p53 colocalize within PODs during Ras-induced arrest.

Conclusions:

  • PML acts in concert with Rb and p53 to mediate Ras-induced senescence.
  • PML localization to PODs is critical for its function in senescence.
  • These findings offer new insights into PML regulation and its role in tumor suppression.

Related Concept Videos